14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.83 $2.67 Wednesday, 24th Apr 2024 CGEN stock ended at $1.91. This is 3.54% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.47% from a day low at $1.90 to a day high of $1.99.
90 days $1.83 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
Feb 12, 2024 $2.16 $2.37 $2.12 $2.33 523 169
Feb 09, 2024 $2.17 $2.21 $2.11 $2.14 352 082
Feb 08, 2024 $2.08 $2.17 $2.08 $2.14 306 226
Feb 07, 2024 $2.24 $2.24 $2.07 $2.10 634 367
Feb 06, 2024 $2.22 $2.34 $2.19 $2.25 613 102
Feb 05, 2024 $2.21 $2.34 $2.14 $2.24 471 542
Feb 02, 2024 $2.41 $2.42 $1.98 $2.27 814 448
Feb 01, 2024 $2.48 $2.57 $2.31 $2.42 570 696
Jan 31, 2024 $2.56 $2.65 $2.39 $2.41 633 405
Jan 30, 2024 $2.58 $2.69 $2.47 $2.57 1 510 326
Jan 29, 2024 $2.15 $2.45 $2.15 $2.43 1 294 832
Jan 26, 2024 $2.13 $2.40 $2.08 $2.21 1 853 474
Jan 25, 2024 $1.92 $2.13 $1.88 $2.11 993 718
Jan 24, 2024 $1.93 $2.03 $1.80 $1.87 806 251
Jan 23, 2024 $1.85 $1.88 $1.84 $1.87 248 459
Jan 22, 2024 $1.90 $1.93 $1.84 $1.86 525 107
Jan 19, 2024 $1.95 $1.95 $1.83 $1.94 642 426
Jan 18, 2024 $1.89 $2.04 $1.87 $1.93 1 232 928
Jan 17, 2024 $1.90 $1.95 $1.84 $1.89 521 011
Jan 16, 2024 $1.79 $1.94 $1.78 $1.92 790 120
Jan 12, 2024 $1.80 $1.91 $1.79 $1.80 404 270
Jan 11, 2024 $1.79 $1.83 $1.74 $1.81 288 156
Jan 10, 2024 $1.77 $1.85 $1.77 $1.80 642 848
Jan 09, 2024 $1.89 $1.94 $1.73 $1.81 1 532 495
Jan 08, 2024 $1.79 $1.94 $1.72 $1.87 945 401
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT